Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Helicobacter Pylori Treatment Could Minimise Gastric Cancer Risk
1
Mins
July 2024
Researchers have unveiled that Helicobacter pylori treatment may be beneficial for individuals with a high genetic risk to gastric cancer.
Read more
1
Mins
19th May 2023
Connection Found Between Cancer Risk and Asthma
Studies reveal that patients with asthma have an elevated risk for several cancer types, (blood, melanoma, ovarian, kidney, and lung cancers)
1
Mins
22nd April 2022
Solving the Mystery of PD-1 Inhibitors
Solved the mystery of how programmed cell death protein 1 (PD-1) inhibitors work on the immune system’s natural killer (NK) cells…
1
Mins
22nd April 2022
Can Vitamin E Enhance Immunotherapy Responses?
VITAMIN E could boost immunotherapy responses, according to researchers at The University of Texas MD Anderson Cancer Center…
1
Mins
29th March 2022
Novel Drug Approved for Treatment of Rare Lung Cancer
A new oral, targeted therapeutic has been approved for the treatment of a rare non-small cell lung cancer, offering improved outcomes…
1
Mins
28th January 2022
Are AI systems Ready to be Introduced into Prostate Cancer Care?
AI systems can identify and grade prostate cancer tissue samples as accurately as pathologists, which could lead to their use as a complementary tool…
1
Mins
28th January 2022
Experts Concerned by the Rise in Young-Onset Cancers
Evidence revealed by researchers at Flinders University and UCLA has demonstrated a rise in gastrointestinal cancers in those under 50…
2
Mins
8th November 2021
Amivantamab Successfully Prolongs Survival in Rare Lung Cancer Mutation
Amivantamab has the potential to address the high unmet need in the treatment of people with EGFR exon 20 insertion mutations in non-small cell lung cancer
1
Mins
22nd October 2021
Two Subtypes of Metastatic Prostate Cancer Identified
Scientists have identified two subtypes of metastatic prostate cancer that responding differently to treatment.
Loading posts...
« Previous
1
…
6
7
8
9
10
…
32
Next »